Search
Mesa Laboratories Inc
MLABAdd to Watchlist
105.540USD
+1.150+1.10%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
583.10MMarket Cap
160.59P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
+1.10%
5 Days
+3.05%
1 Month
-3.29%
6 Months
+32.87%
Year to Date
+34.45%
1 Year
+2.07%
Key Figures
105.010Open
107.675High
117.34KVolume
160.59P/E TTM
70.82P/E Dynamic
0.640Dividend TTM
2.12%Turnover Ratio
104.390Prev. Close
103.610Low
6.45MTurnover
LossP/E Static
3.13P/B
0.61%Div Yield TTM
0.86%ROA
111.29052wk High
1.13Volume Ratio
-1.97MNet Profit
5.52MShares
0.6572EPS TTM
0.94Beta
2.18%ROE
55.45052wk Low
3.89%Amplitude
66.23%Gross Margin
583.10MMarket Cap
-1.17Reward/Risk
3.71%Risk Rate
TradingKey Stock Score of Mesa Laboratories Inc
Currency: USD Updated: 2026-07-02Key Insights
Mesa Laboratories Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 35 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 112.00.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Mesa Laboratories Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Mesa Laboratories Inc Highlights
StrengthsRisks
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 15.24% year-on-year.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 160.59, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.55M shares, decreasing 4.38% quarter-over-quarter.
Held by Chuck Royce
Star Investor Chuck Royce holds 157.05K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.38.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
112.000
Target Price
+7.29%
Upside Space
Mesa Laboratories Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Mesa Laboratories Inc Info
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Ticker SymbolMLAB
CompanyMesa Laboratories Inc
CEOOwens (Gary M)
Websitehttps://mesalabs.com
Related Instruments
-0.37%
+1.91%
+3.48%
+5.87%
+2.10%
-0.10%
+4.19%
+5.03%
+4.30%
+0.25%
+3.65%
+4.74%
+2.79%
+2.59%
-3.06%
+3.40%
+3.76%
+1.10%
+0.28%
-2.09%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Mesa Laboratories Inc (MLAB)?
The current price of Mesa Laboratories Inc (MLAB) is 105.54.
What is the symbol of Mesa Laboratories Inc?
The ticker symbol of Mesa Laboratories Inc is MLAB.
What is the 52-week high of Mesa Laboratories Inc?
The 52-week high of Mesa Laboratories Inc is 111.29.
What is the 52-week low of Mesa Laboratories Inc?
The 52-week low of Mesa Laboratories Inc is 55.45.
What is the market capitalization of Mesa Laboratories Inc?
The market capitalization of Mesa Laboratories Inc is 583.10M.
Is Mesa Laboratories Inc (MLAB) currently rated as Buy, Hold, or Sell?
According to analysts, Mesa Laboratories Inc (MLAB) has an overall rating of Buy, with a price target of 112.00.
What is the Earnings Per Share (EPS TTM) of Mesa Laboratories Inc (MLAB)?
The Earnings Per Share (EPS TTM) of Mesa Laboratories Inc (MLAB) is 1.22.